European survey on the current surveillance practices, management guidelines, treatment pathways, and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).

Viprey, Virginie FGranata, GuidoVendrik, Karuna EwDavis, Georgina LPetrosillo, NicolaKuijper, Ed JVilken, TubaLammens, ChristineSchotsman, Joost JBenson, Anthony DCataldo, Maria Adrianavan der Kooi, TjallieWilcox, Mark HDavies, Kerrie ABonten, MarcDavies, Kerrie AWilcox, Mark HKuijper, EdRupnik, MajaWingen-Heimann, SebastianTacconelli, EvelinaVilken, TubaPetrosillo, NicolaBonten, MarcCleuziat, PhilippeWebber, ChrisRupnik, MajaWilcox, Mark2022-12-132022-12-132022-12-123646267310.1016/j.jhin.2022.11.011http://hdl.handle.net/10029/626310enCopyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.Clostridioides difficileClostridium difficilediagnosisguidelines awarenesstreatmentEuropean survey on the current surveillance practices, management guidelines, treatment pathways, and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).Article1532-2939The Journal of hospital infection 2023; 131:213-220